Profile | GDS4284 / 232432_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1921.35 | 83 |
GSM687648 | Patient 402 control | 1872.55 | 83 |
GSM687653 | Patient 403 control | 2293.7 | 86 |
GSM687658 | Patient 404 control | 1296.68 | 78 |
GSM687663 | Patient 411 control | 1371.61 | 79 |
GSM687668 | Patient 422 control | 2019.31 | 84 |
GSM687673 | Patient 424 control | 1712.03 | 82 |
GSM687678 | Patient 425 control | 1624.48 | 81 |
GSM687683 | Patient 427 control | 1421.36 | 79 |
GSM687688 | Patient 428 control | 1344.53 | 78 |
GSM687695 | Patient 441 control | 1268.52 | 79 |
GSM687699 | Patient 443 control | 1463.37 | 80 |
GSM687704 | Patient 444 control | 1439.39 | 79 |
GSM687707 | Patient 448 control | 1951.69 | 84 |
GSM687712 | Patient 449 control | 1724.94 | 82 |
GSM687719 | Patient 450 control | 1378.54 | 79 |
GSM687724 | Patient 451 control | 1646.07 | 82 |
GSM687728 | Patient 452 control | 2118.17 | 85 |
GSM687646 | Patient 401 treated 24h | 1905.05 | 83 |
GSM687649 | Patient 402 treated 24h | 1901.61 | 83 |
GSM687665 | Patient 411 treated 24h | 1410.66 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 1816.09 | 82 |
GSM687667 | Patient 411 treated 4 weeks | 2275.02 | 85 |
GSM687670 | Patient 422 treated 24h | 2045.28 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 2383.22 | 86 |
GSM687654 | Patient 403 treated 24h | 2202.99 | 85 |
GSM687675 | Patient 424 treated 24h | 2081.41 | 85 |
GSM687685 | Patient 427 treated 24h | 1394.24 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 2446.75 | 86 |
GSM687677 | Patient 424 treated 4 weeks | 1273.19 | 77 |
GSM687687 | Patient 427 treated 4 weeks | 1928.99 | 83 |
GSM687692 | Patient 428 treated 4h | 1258.48 | 77 |
GSM687716 | Patient 449 treated 4h | 1660.42 | 81 |
GSM687722 | Patient 450 treated 4h | 1322.36 | 78 |
GSM687680 | Patient 425 treated 24h | 1731.34 | 82 |
GSM687690 | Patient 428 treated 24h | 1097.06 | 76 |
GSM687700 | Patient 443 treated 24h | 986.266 | 73 |
GSM687705 | Patient 444 treated 24h | 1278.88 | 78 |
GSM687714 | Patient 449 treated 24h | 1817.76 | 83 |
GSM687721 | Patient 450 treated 24h | 1357.02 | 79 |
GSM687682 | Patient 425 treated 4 weeks | 1179.19 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 1500.43 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 1402.62 | 79 |
GSM687718 | Patient 449 treated 4 weeks | 1492.77 | 80 |
GSM687723 | Patient 450 treated 4 weeks | 1448.77 | 80 |
GSM687661 | Patient 404 treated 4h | 1304.24 | 78 |
GSM687710 | Patient 448 treated 4h | 1969.92 | 84 |
GSM687726 | Patient 451 treated 4h | 1748.52 | 82 |
GSM687730 | Patient 452 treated 4h | 598.273 | 61 |
GSM687660 | Patient 404 treated 24h | 869.094 | 74 |
GSM687697 | Patient 441 treated 24h | 1142.2 | 77 |
GSM687709 | Patient 448 treated 24h | 2296.68 | 86 |
GSM687725 | Patient 451 treated 24h | 1562.19 | 81 |
GSM687729 | Patient 452 treated 24h | 1213.79 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 1167.45 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 1857.34 | 83 |